1. AB0738 Secukinumab Reduces Hscrp Levels in Subjects with Moderate-To-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis: A Sub-Analysis from the Phase 3 Erasure Study. (10th June 2014) Authors: Gottlieb, A.; Sigurgeirsson, B.; Blauvelt, A.; Gong, Y.; Papavassilis, C.; Mpofu, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adiponectin levels in a large pooled plaque psoriasis study population. (3rd July 2020) Authors: Gerdes, S.; Pinter, A.; Biermann, M.; Papavassilis, C.; Reinhardt, M. Journal: Journal of dermatological treatment Issue: Volume 31:Number 5(2020) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients. (10th October 2019) Authors: Gerdes, S.; Pinter, A.; Papavassilis, C.; Reinhardt, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 3(2020) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study. (18th January 2013) Authors: Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; Haemmerle, S.; Thurston, H.J.; Papavassilis, C.; Richards, H.B. Journal: British journal of dermatology Issue: Volume 168:Number 2(2013:Feb.) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE). (22nd September 2014) Authors: Paul, C.; Lacour, J.‐P.; Tedremets, L.; Kreutzer, K.; Jazayeri, S.; Adams, S.; Guindon, C.; You, R.; Papavassilis, C.; the JUNCTURE study group Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 6(2015:Jun.) Page Start: 1082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate‐to‐severe plaque psoriasis. (22nd December 2017) Authors: Strober, B.E.; Langley, R.G.B.; Menter, A.; Magid, M.; Porter, B.; Fox, T.; Safi, J.; Papavassilis, C. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled JUNCTURE trial. (23rd January 2017) Authors: Lacour, J.‐P.; Paul, C.; Jazayeri, S.; Papanastasiou, P.; Xu, C.; Nyirady, J.; Fox, T.; Papavassilis, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 5(2017) Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secukinumab administration by pre‐filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). (11th December 2014) Authors: Blauvelt, A.; Prinz, J.C.; Gottlieb, A.B.; Kingo, K.; Sofen, H.; Ruer‐Mulard, M.; Singh, V.; Pathan, R.; Papavassilis, C.; Cooper, S.; the FEATURE Study Group Journal: British journal of dermatology Issue: Volume 172:Number 2(2015:Feb.) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Secukinumab administration by pre‐filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). (1st February 2015) Authors: Blauvelt, A.; Prinz, J.C.; Gottlieb, A.B.; Kingo, K.; Sofen, H.; Ruer‐Mulard, M.; Singh, V.; Pathan, R.; Papavassilis, C.; Cooper, S. Journal: British journal of dermatology Issue: Volume 172:Number 2(2015:Feb.) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗